BAXTER'S $80 MIL. PURCHASE OF PERFUSION SERVICES FIRM PSICOR INTENDED TO EXPAND CAPITATED CARDIOVASCULAR OFFERINGS; PSICOR SERVES 400 HOSPITALS
This article was originally published in The Gray Sheet
Executive SummaryBaxter Healthcare is expanding the perfusion service component of its cardiovascular business with the planned acquisition of perfusion service provider Psicor for about $80 mil.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.